News

A prediction by QuintilesIMS consultants states that the industry can look forward to a historically large number and quality of new medicines emerging from the research and development pipeline over the next five years.

This article provides the necessary steps to advance past Phase II clinical trials on the way toward delivering an impactful drug to market.

The European Reference Network on Rare Respiratory Diseases-a grouping of specialists from more than 60 dispersed centers-has won approval of EU funding to maximize clinical trial efficiency in Europe.

Conducting a clinical trial is a difficult process no matter the factors involved, but become especially challenging when ran from sites that have no prior experience and limited resources. A little preparation and forward thinking can go a long way in reducing data loss and executing a successful study.

Moffitt Cancer Center has chosen cryogenic logistics company, Cryoport to provide support for its immunology program, cancer research, therapy programs and lab moves.

The AAHRPP announced that it has accredited four research organizations which include two academic medical centers, a research university and a premier, globally recognized cancer center.

As business grows with the addition of more CROs, questions have arisen from sponsors about how to conduct effective CRO oversight. A survey of clinical leaders provides insights to help address key challenges and regulations more quickly and effectively.

Comparing mean vs. median to uncover the full data picture of site-level performance.

The European Medicines Agency will launch a pilot project in February 2017 to test the added value and feasibility of tailored scientific advice for the development of biosimilar medicines.

Schulman IRB has announced that they will join both IRBchoice and SMART IRB Reliance Networks.

Commonwealth Informatics has signed a new contract to support the use of advanced drugs safety tools at the FDA Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research.

The Almac Group has announced a collaboration with cloud-based solution provider Exostar.

Specimatch announced the launch of its web-based software service for cancer patients and oncologists.

PPD has announced an expansion of its stability sample storage capacity and capabilities.

Spare a thought for your Scandinavian colleagues who are running CROs

The Alliance for Clinical Research Excellence and Safety (ACRES) has partnered with the British Standards Institution (BSI) to launch a multi-stakeholder global working party.

Endpoint adjudication is gaining importance in pharma today, however, no guidance on endpoint adjudication currently exists. The LinkedIn Endpoint Adjudication Community has generated an Events Charter Template to shed light on the subject for those in need of guidance.

The advancement of technology has allowed for new solutions to become available in all areas of clinical trials. Patient Recruitment Systems are no exception as they can be used to improve the trial process by optimizing protocols, selecting high potential sites and enabling more studies.